PHARMACY

CVS Health to support Anthem’s newly launched IngenioRx PBM

BY David Salazar

WOONSOCKET, R.I. — Health benefits company Anthem’s new pharmacy benefits manager IngenioRx will be getting an assist from CVS Health. The companies inked a five-year agreement that will see CVS Health’s Caremark PBM managing such services as claims processing and prescription fulfillment services for IngenioRx.

CVS Health also will leverage its CVS Pharmacy and MinuteClinic assets to bring its point-of-sale patient messaging and engagement tools to bear on its support of IngenioRx. The company said that by broadening the scope of clinical services offered at the pharmacy, it would drive better health outcomes.

“We believe that this agreement further validates the important role that CVS Health's integrated and innovative pharmacy care model plays in today's health care system and we look forward to working with Anthem and IngenioRx to provide services to help ensure coordinated, holistic care for their PBM members,” CVS Health president and CEO Larry Merlo said. “At CVS Health, we truly are the front door of health care, with nearly 5 million Americans walking into a CVS Pharmacy every day. Given our presence in the community, our pharmacists and nurse practitioners are able to engage in face-to-face personalized counseling and clinically-effective interventions that will enable us to help improve health outcomes and lower overall health care costs for Anthem and its members.”

The agreement will go into effect on Jan. 1, 2020.

“This combination, paired with the clinical expertise, deep provider relationships and focus on customer centricity of Anthem’s affiliated health plans, will create a holistic, integrated approach to managing health and driving better outcomes,” Anthem EVP commercial and specialty division Brian Griffin said “In partnership with CVS, transitioning members seamlessly to our new solution will remain Anthem’s top priority.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Q&A: Anda’s Chip Phillips talks company’s 25-year growth

BY DSN STAFF
October marks Anda’s 25th anniversary of providing pharmaceutical distribution throughout the nation. Drug Store News spoke with Anda president Chip Phillips about how the company and industry has changed over a quarter of a century.

DSN: What do you think has been the key contributing factor to Anda’s success?
Chip Phillips: Our service orientation. We focus on the critical role of connecting our customers and suppliers. We never lose sight of patient needs in association with the availability of medication.
 
DSN: What significant changes, if any, did Anda make to the business over the past 25 years?
Phillips: Anda started in 1992 as a generic distributor specializing in new product launches servicing community pharmacies. Over the years, we developed capabilities to service large corporate chain customers. In doing so, we have become a permanent part of the pharmaceutical supply chain infrastructure.
 
DSN: What makes Anda different than the other wholesalers and distributors?
Phillips: Our flexibility and willingness to provide customized programs that are meaningful to our customers and manufacturer partners. Our “Customer Dedicated Inventory” program is a great example of this. 
 
DSN: Can you explain what this program is?  
Phillips: Basically with our “Customer Dedicated Inventory” program Anda serves as an extension of our customer’s distribution centers. We systematically guarantee inventory, so that your product is for your use only.  
 
DSN: How has Anda’s role as a distributor evolved as a result of the challenges that exist throughout the industry today, including the press-ures of pricing, de-clining margins and increased competition? 
Phillips: In some ways, Anda hasn’t changed at all. Anda’s reputation for providing reliable and compliant pharmaceutical distribution services at market competitive pricing is who we are and what makes us proud. Anda always has wanted our customers to know that they can count on us. We get them what they need, when they need it. That hasn’t changed. As a secondary supplier, that is the core of what is most important in the service we provide. In other ways, Anda has evolved into a sophisticated organization like many of our large competitors through the investment in technology, advanced analytical capabilities and people. 
 
DSN: What changes do you see for the industry in the near future?
Phillips: Maintenance of the integrity of the supply chain is of critical importance. Accordingly, the implementation of the Drug Supply Chain Security Act is a high priority. We also anticipate a move toward more drug pricing transparency.
 

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
PHARMACY

Teva introduces Testim generic

BY David Salazar

JERUSALEM — Teva on Wednesday announced the introduction of its generic of Testim (testosterone gel, 1%). The company received approval for the generic from the Food and Drug Administration in September.

Teva’s generic is available as 50 mg in a 5-gm tube. The product is indicated for testosterone replacement therapy in adult males for conditions associated with the deficiency or absence of endogenous testosterone. It carries a boxed warning for secondary exposure to testosterone.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?